What Researchers Did
Researchers evaluated the clinical aspects, diagnostic investigations, and management of bisphosphonate-associated osteonecrosis of the jaws (ONJ) in a series of 12 patients.
What They Found
Of the 12 patients, 11 were symptomatic, experiencing swelling, fever, and bone exposure, while one asymptomatic case was an incidental finding. Histological investigations confirmed avascular and necrotic tissue, and microbiological analysis revealed pathogenic microorganisms in the majority of patients. Treatment involving antibiotics, minor surgical interventions, and hyperbaric oxygen therapy provided short-term symptomatic relief.
What This Means for Canadian Patients
Canadian patients on intravenous bisphosphonates should be vigilant for symptoms like swelling or bone exposure in the jaw and seek prompt dental or medical evaluation. A comprehensive diagnostic approach, including imaging and microbiological tests, followed by appropriate management, can help address this serious complication.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The study's small sample size of 12 patients and the lack of reported long-term follow-up limit the generalizability of its findings.